MA31356B1 - Utilisation d'inhibiteurs de la hdac pour le traitement des cancers gastro-intestinaux - Google Patents
Utilisation d'inhibiteurs de la hdac pour le traitement des cancers gastro-intestinauxInfo
- Publication number
- MA31356B1 MA31356B1 MA32315A MA32315A MA31356B1 MA 31356 B1 MA31356 B1 MA 31356B1 MA 32315 A MA32315 A MA 32315A MA 32315 A MA32315 A MA 32315A MA 31356 B1 MA31356 B1 MA 31356B1
- Authority
- MA
- Morocco
- Prior art keywords
- treatment
- gastrointestinal cancers
- hdac inhibitors
- relates
- hdac
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La présente invention concerne l'utilisation d'un inhibiteur de la hdac pour préparer un médicament destiné au traitement des cancers gastro-intestinaux. L'invention concerne également un procédé de traitement d'un animal à sang chaud, en particulier un être humain, ayant un cancer gastro-intestinal, ledit procédé comprenant l'administration audit animal d'une quantité thérapeutiquement efficace d'un inhibiteur de la hdac, en particulier un composé de formule (i) tel que défini ici. L'invention concerne en outre une composition pharmaceutique et un emballage commercial.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91599607P | 2007-05-04 | 2007-05-04 | |
PCT/US2008/062341 WO2008137630A1 (fr) | 2007-05-04 | 2008-05-02 | Utilisation d'inhibiteurs de la hdac pour le traitement des cancers gastro-intestinaux |
Publications (1)
Publication Number | Publication Date |
---|---|
MA31356B1 true MA31356B1 (fr) | 2010-05-03 |
Family
ID=39683987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA32315A MA31356B1 (fr) | 2007-05-04 | 2009-10-30 | Utilisation d'inhibiteurs de la hdac pour le traitement des cancers gastro-intestinaux |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP2142190A1 (fr) |
JP (1) | JP2010526149A (fr) |
KR (1) | KR20100016171A (fr) |
CN (1) | CN101674825A (fr) |
AU (1) | AU2008247603A1 (fr) |
BR (1) | BRPI0811112A2 (fr) |
CA (1) | CA2683554A1 (fr) |
CL (1) | CL2008001269A1 (fr) |
IL (1) | IL201318A0 (fr) |
MA (1) | MA31356B1 (fr) |
MX (1) | MX2009011692A (fr) |
RU (1) | RU2009144842A (fr) |
TN (1) | TN2009000427A1 (fr) |
TW (1) | TW200908964A (fr) |
WO (1) | WO2008137630A1 (fr) |
ZA (1) | ZA200906739B (fr) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20020354A1 (es) * | 2000-09-01 | 2002-06-12 | Novartis Ag | Compuestos de hidroxamato como inhibidores de histona-desacetilasa (hda) |
AU2004284030A1 (en) * | 2003-10-27 | 2005-05-06 | S*Bio Pte Ltd | Acylurea connected and sulfonylurea connected hydroxamates |
TW200524575A (en) * | 2003-10-27 | 2005-08-01 | S Bio Pte Ltd | Biaryl linked hydroxamates: preparation and pharmaceutical applications |
WO2006075165A1 (fr) * | 2005-01-13 | 2006-07-20 | Btg International Limited | Combinaison de virus oncolytiques a des inhibiteurs d'angiogenese |
-
2008
- 2008-05-02 JP JP2010507547A patent/JP2010526149A/ja not_active Withdrawn
- 2008-05-02 MX MX2009011692A patent/MX2009011692A/es not_active Application Discontinuation
- 2008-05-02 AU AU2008247603A patent/AU2008247603A1/en not_active Abandoned
- 2008-05-02 CN CN200880014107A patent/CN101674825A/zh active Pending
- 2008-05-02 TW TW097116351A patent/TW200908964A/zh unknown
- 2008-05-02 RU RU2009144842/15A patent/RU2009144842A/ru not_active Application Discontinuation
- 2008-05-02 CL CL2008001269A patent/CL2008001269A1/es unknown
- 2008-05-02 EP EP08747442A patent/EP2142190A1/fr not_active Withdrawn
- 2008-05-02 BR BRPI0811112-0A2A patent/BRPI0811112A2/pt not_active IP Right Cessation
- 2008-05-02 KR KR1020097022965A patent/KR20100016171A/ko not_active Application Discontinuation
- 2008-05-02 CA CA002683554A patent/CA2683554A1/fr not_active Abandoned
- 2008-05-02 WO PCT/US2008/062341 patent/WO2008137630A1/fr active Application Filing
-
2009
- 2009-09-28 ZA ZA200906739A patent/ZA200906739B/xx unknown
- 2009-10-01 IL IL201318A patent/IL201318A0/en unknown
- 2009-10-16 TN TNP2009000427A patent/TN2009000427A1/fr unknown
- 2009-10-30 MA MA32315A patent/MA31356B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
EP2142190A1 (fr) | 2010-01-13 |
MX2009011692A (es) | 2009-11-10 |
IL201318A0 (en) | 2010-05-31 |
JP2010526149A (ja) | 2010-07-29 |
TN2009000427A1 (en) | 2011-03-31 |
TW200908964A (en) | 2009-03-01 |
BRPI0811112A2 (pt) | 2014-12-23 |
CA2683554A1 (fr) | 2008-11-13 |
KR20100016171A (ko) | 2010-02-12 |
ZA200906739B (en) | 2010-06-30 |
CL2008001269A1 (es) | 2008-12-19 |
RU2009144842A (ru) | 2011-06-10 |
CN101674825A (zh) | 2010-03-17 |
WO2008137630A1 (fr) | 2008-11-13 |
AU2008247603A1 (en) | 2008-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA31496B1 (fr) | Inhibiteurs macrocycliques innovants de la replication du virus de l'hepatite c | |
UA101601C2 (uk) | Інгібітори амідогідролази жирних кислот | |
MA33467B1 (fr) | Promédicaments comprenant un conjugué insuline-lieur | |
BR0214343A (pt) | Inibidores de 11 - beta - hidroxi esteróide desidrogenase tipo 1 | |
WO2001081310A8 (fr) | 1-aroyle-piperidinyle benzamidines | |
EA200971041A1 (ru) | Новые пептидные ингибиторы репликации вируса гепатита с | |
HK1091481A1 (en) | Therapeutic agents useful for treating pain | |
CR8603A (es) | Hidrocloruro de [4-(5-aminometil-2-fluoro-fenil)-piperidin-1-il]-(4-bromo-3-metil-5-propoxi-tiofen-2-il)-metanona como un inhibidor de la triptasa de mastocitos | |
NZ592425A (en) | Isoindoline compounds for use in the treatment of cancer | |
MA31761B1 (fr) | Nouveaux inhibiteurs de seh et leur utilisation | |
MA32225B1 (fr) | Nouveaux inhibiteurs macrocycliques de la replication du virus de l'hepatite c | |
MA34474B1 (fr) | Agonistes de gpr40 | |
MX2009008439A (es) | Nuevos inhibidores de la replicacion del virus de hepatitis c. | |
WO2009039397A3 (fr) | Amides substitués, procédé pour les préparer et procédé pour les utiliser | |
MX2007009649A (es) | Derivados de meleimida, composiciones farmaceuticas y metodos para el tratamiento del cancer. | |
MA33178B1 (fr) | Pipéridines substituées comme antagonistes de ccr3 | |
MA30351B1 (fr) | Composes de tetrahydropyridothienopyrimidine et leurs procedes d'utilisation | |
MA35363B1 (fr) | Utilisation d'un composé organisation dans le traitement du syndrome de noonan | |
NO20043367L (no) | Oralt farmasoytisk preparat | |
MA33923B1 (fr) | Dérivés hétéroaromatiques de phénylimidazole en tant qu'inhibiteurs de l'enzyme pde10a | |
UA97348C2 (en) | HETEROCYCLIC NF-kB INHIBITORS | |
AU2009246603A8 (en) | Von willebrand factor (vwf) inhibitors for treatment or prevention of infarction | |
MXPA05000765A (es) | Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos. | |
DE60230155D1 (de) | Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung | |
MY156278A (en) | Disubstituted [4-(5-aminomethyl-phenyl)-piperidin-1-yl]-1h-indol-3-yl]-methanones |